18361-50-7 Usage
General Description
Leukomycin A8 is a cytotoxic polyketide compound produced by the soil bacterium Streptomyces through a type I polyketide synthesis pathway. It belongs to a class of antibiotics that have shown potent anticancer activity in various tumor models. Leukomycin A8 works by inducing cell cycle arrest and promoting apoptosis in cancer cells, making it a promising candidate for anti-cancer drug development. Studies have shown that Leukomycin A8 inhibits the proliferation of cancer cells by targeting key signaling pathways involved in cell growth and survival. Its ability to selectively target cancer cells while sparing normal cells makes it a valuable compound for potential therapeutic applications in cancer treatment.
Check Digit Verification of cas no
The CAS Registry Mumber 18361-50-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,8,3,6 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 18361-50:
(7*1)+(6*8)+(5*3)+(4*6)+(3*1)+(2*5)+(1*0)=107
107 % 10 = 7
So 18361-50-7 is a valid CAS Registry Number.
InChI:InChI=1/C39H63NO15/c1-21-18-27(16-17-41)35(36(48-10)29(52-25(5)42)19-30(45)49-22(2)14-12-11-13-15-28(21)44)55-38-33(46)32(40(8)9)34(23(3)51-38)54-31-20-39(7,47)37(24(4)50-31)53-26(6)43/h11-13,15,17,21-24,27-29,31-38,44,46-47H,14,16,18-20H2,1-10H3/b12-11+,15-13+/t21-,22-,23-,24+,27+,28+,29-,31+,32-,33-,34-,35+,36+,37+,38+,39-/m1/s1
